Sphera Funds Management Ltd. Verrica Pharmaceuticals Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$7.95 - $14.07 $771,150 - $1.36 Million	-97,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.75 - $16.12 $135,000 - $322,400	-20,000 Reduced 17.09%	97,000 $791,000
Q3 2018 Nov 14, 2018	SELL	$13.94 - $19.88 $122,672 - $174,944	-8,800 Reduced 7.0%	117,000 $1.9 Million
Q2 2018 Aug 13, 2018	BUY	$17.5 - $20.34 $2.2 Million - $2.56 Million	125,800 New	125,800 $2.48 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.